Construction of a dietary-cure Saccharomyces cerevisiae expressing long-acting glucagon-like peptide-1 and investigation of its hypoglycemic activity in type 2 diabetes mellitus mouse model
- 80 Downloads
Bio-drug is a new type of beneficial biology expressing therapeutic peptides (protein) as orally administrated medicine to treat diseases, in particular, chronic diseases like diabetes. In order to develop recombinant yeast strains as a bio-drug which could effectively ameliorate type 2 diabetes, an integrating expression vector pNK1-PGK that could successfully express green fluorescent protein (GFP) in Saccharomyces cerevisiae was constructed to demonstrate the normality of the function. A pNK1-PGK vector, which expresses 10 tandem repeats of long-acting glucagon-like peptide-1(10laGLP-1), was cloned and then transformed into the S. cerevisiae INVSc1. The long-acting GLP-1 hypoglycemic yeast (LHY168) that grew rapidly and expressed 10laGLP-1 stably was screened by uracil-deficient plates and Western blot. The expression quantity of 10laGLP-1 reached 1.56 mg/g cell wet weight. Moreover, the oral administration of LHY168 significantly declined the blood glucose in type 2 diabetic mice that were constructed through co-induction of streptozotocin (STZ) and high-fat and high-sugar diet.
KeywordsLong-acting GLP-1 hypoglycemic yeast (LHY) long-acting glucagon-like peptide-1(10laGLP-1) recombinant yeast type 2 diabetes
This work is supported by the National Natural Science Foundation of China (31771066) and the Key Technologies R&D Program of Tianjin (18YFZCSY00030 and 18YFZCNC01200).
- Amberg DC 2009 Experimental guide to the method of yeast genetics (The Science Publishing Company)Google Scholar
- Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B and Group L-S 2009 Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial. Lancet 373 473–481CrossRefGoogle Scholar
- Sahay M, et al. 2017 Diabetes and Anemia: International Diabetes Federation (IDF) - Southeast Asian Region (SEAR) position statement. Diabetes Metab. Syndr. 11 Suppl 2 S685–S695Google Scholar
- Wu ZQ, Jia NB, Li N, Ma BC and Li MG 2009 Construction of Saccharomyces cerevisiae strain stably expressing a fusion protein containing ten tandem recombinant human glucagon-like peptide-1 analogues. Chem. Res. Chin. Univ. 25 882–886Google Scholar